Oncoginase 5000IU Injection

Prezentare produs

About Oncoginase

Oncoginase is a medication containing the active ingredient Asparaginase, classified as Asparagine-specific Enzyme. Asparaginase is an enzyme that is used as a medication and in food manufacturing. As a medication, L-asparaginase is used to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL). It is given by injection into a vein, or muscle. A PEGylated version, pegaspargase, is also available.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE RYLAZE is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic.
• Used for: coli -derived asparaginase
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Asparaginase, the active ingredient in Oncoginase, belongs to the Asparagine-specific Enzyme class. 1 INDICATIONS AND USAGE RYLAZE is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adult and pediatric patients 1 month or older who have developed hypersensitivity to E. coli -derived asparaginase. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Oncoginase. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Oncoginase for extended periods without medical advice.